Neoadjuvant Novel Hormonal Agents Studied in High - Risk Prostate Cancer
Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis - free survival
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Surgery, Urology, Journal, Source Type: news
More News: Cancer | Cancer & Oncology | Hormones | Neoadjuvant Therapy | Prostate Cancer | Urology & Nephrology